MedTrace Logo

Desensitization Protocol for Deceased Donor List

NCT01642225 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2014-10-20

No results posted yet for this study

Summary

Purpose of the study:

The specific aims of this study are to evaluate overall efficacy and safety of the pre-transplant IVIG treatment in our transplant center since 2007 and to identify factors affecting treatment outcomes in order to improve patient selection and treatment protocols for future patients.

Conditions

  • Transplant; Failure, Kidney

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Junichiro Sageshima, M.D. · University of Miami

Eligibility

Min Age
7 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01642225 on ClinicalTrials.gov